

There are oral medications that may be used for excessive sweating. These treatments may be considered especially in patients who sweat in more than one area, do not obtain sufficient benefit from local treatments, or have widespread involvement of areas such as the hands, feet, underarms, face, and scalp.
Oral medications act on neural or hormonal mechanisms that affect sweat gland activity. The most commonly considered group is anticholinergic medications. In selected situations, beta blockers, anti-anxiety medications, clonidine, or medications targeting an underlying cause may also be considered.
However, oral medication is not suitable for every patient with excessive sweating. These medications may affect not only the sweating area but also different systems throughout the body. Side effects such as dry mouth, constipation, blurred vision, difficulty urinating, palpitations, drowsiness, and heat intolerance may occur.
For this reason, oral medication should not be regarded as a simple supplement that can be started without medical evaluation. First, it should be determined whether the sweating is primary hyperhidrosis or secondary sweating related to another disease, medication, hormonal change, or metabolic problem.
Oral medications may be considered especially when local treatments are insufficient or when sweating affects more than one area.
Medication treatment may be considered when:
Because oral medications can act throughout the body, they may not be the first option for every person whose sweating is limited to one small area.
For example, in a person with sweating limited only to the underarms, antiperspirants, topical medications, or botulinum toxin may be more targeted options. In contrast, when several areas such as the face, scalp, hands, feet, and trunk are affected, systemic treatments may become more relevant.
The cause of sweating should be evaluated before oral medication is planned.
Primary hyperhidrosis is excessive sweating that cannot be explained by another disease or medication. It usually begins during childhood, adolescence, or young adulthood. It may affect specific areas such as the hands, feet, underarms, and face. It is usually bilateral and symmetrical. It decreases or stops during sleep.
Secondary hyperhidrosis develops due to another cause.
Causes of secondary sweating may include:
In secondary sweating, using a medication that only suppresses sweating may not solve the main problem. For example, if sweating is caused by thyroid disease, the priority is to treat the thyroid condition. If sweating is caused by low blood sugar, blood glucose should be regulated. If sweating is medication-related, the dose or alternative options should be evaluated by the prescribing doctor.
Oral medications used for excessive sweating can be grouped into different categories. The most appropriate medication depends on the type and severity of sweating, the patient’s age, accompanying diseases, and other medications being used.
Medication groups that may be considered include:
These medications are not all used for the same purpose or in the same patient group. Some aim to directly reduce sweat gland activity, while others may help reduce palpitations, anxiety, hot flashes, or other mechanisms that trigger sweating.
Anticholinergic medications reduce the effect of a chemical substance called acetylcholine.
Sweat glands are stimulated through acetylcholine released from nerve endings. Acetylcholine sends the sweat glands the signal to “work.” Anticholinergic medications may reduce sweat production by weakening this signal.
Anticholinergic medications used or considered in the treatment of excessive sweating may include:
These medications may not have the same approval status or frequency of use in every country. Some uses may be off-label. Off-label use means that a doctor recommends a medication outside its approved indication based on scientific evidence and clinical assessment. This does not necessarily mean the treatment is inappropriate, but the expected benefit, risks, and alternatives should be clearly explained to the patient.
Sweat glands are controlled by the autonomic nervous system. This system regulates many functions that work outside conscious control, such as heart rate, digestion, pupil size, saliva production, and sweating.
Acetylcholine plays an important role in the nerve signal reaching the sweat glands. Anticholinergic medications may help the sweat glands work less by reducing the effect of acetylcholine.
These medications do not affect only the sweat glands. They may also affect other systems where acetylcholine has a role.
For this reason, people using anticholinergic medications may experience:
The benefit and side effects of anticholinergic medications arise from the same mechanism. The system that reduces sweating may, unfortunately, also turn the mouth into a desert. The body does enjoy dramatic details.
Oxybutynin is an anticholinergic medication. It is mainly known for its effects on the bladder muscle. However, it may also be considered to reduce sweating in some patients with hyperhidrosis.
Oxybutynin may be considered especially when:
The effect of oxybutynin on sweating varies from person to person. It may provide significant relief in some patients, while in others it may not be continued because of side effects.
One of the most common problems is dry mouth. Constipation, blurred vision, difficulty urinating, and discomfort in hot weather may also occur.
Glycopyrrolate or glycopyrronium is an anticholinergic medication. In excessive sweating, it may be considered as an oral medication or, in some countries, in topical forms.
The oral form may help reduce the general activity of the sweat glands. It may be considered by a doctor, especially in people with facial, scalp, or multi-area sweating.
Glycopyrrolate is sometimes considered an anticholinergic that may have more limited central nervous system side effects in some patients. However, this does not mean that the medication has no side effects.
Possible side effects include:
The approval status of glycopyrrolate may vary according to country and intended use. For this reason, the patient should clarify with the doctor why and within what context the treatment is being recommended.
Propantheline and benztropine are also among medications with anticholinergic effects. They may be considered in some patients with hyperhidrosis.
However, their use depends on the patient’s general health, other medications, risk of side effects, and local approval status.
Similar side effects may be seen across anticholinergic medications:
For this reason, medication selection should be based less on “Which drug is stronger?” and more on “Which medication is safer and more tolerable for this patient?”
Beta blockers are not primary hyperhidrosis medications that directly target the sweat glands. However, in some people, they may be considered in specific situations to reduce physical anxiety symptoms that trigger sweating.
For example, beta blockers such as propranolol may reduce palpitations, trembling, and physical tension in situations such as:
When these physical symptoms decrease, sweating may also indirectly improve.
Beta blockers are not considered a standard treatment for continuous and widespread hyperhidrosis. They are more relevant in people whose sweating increases during specific performance-related situations and is associated with physical anxiety symptoms.
These medications may not be suitable for people with asthma, certain heart rhythm problems, low blood pressure, low heart rate, or certain vascular diseases. They should not be used without medical evaluation.
In some people, sweating may increase significantly with social anxiety, panic symptoms, or performance anxiety.
Anti-anxiety medications do not directly target the sweat glands. However, by reducing the physical effects of anxiety, they may indirectly ease sweating in certain situations.
Medications in this group may be considered particularly for short-term or specific situations. However, long-term use requires caution because of issues such as sedation, reduced attention, risk of dependence, and development of tolerance.
If sweating is related to social anxiety, medication alone may not be sufficient. Psychotherapy, especially cognitive behavioural therapy, may also be important.
If a person has entered a cycle of “I become anxious because I sweat” and “I sweat more because I become anxious,” both the sweating and the anxiety cycle should be addressed.
Clonidine is a medication that may be considered in some cases of sweating and hot flashes. It may be considered by a doctor particularly in conditions such as menopausal hot flashes, medication-related sweating, or facial and scalp sweating.
Clonidine is not suitable for everyone.
Possible side effects include:
People taking blood pressure medication, those with low blood pressure, or those with heart rhythm problems require careful evaluation.
Clonidine should not be started without medical advice and should not be stopped suddenly without medical advice.
Antidepressants are not usually considered direct “sweating medications” for excessive sweating. However, they may be used to treat conditions such as social anxiety disorder, panic disorder, or depression if these conditions increase sweating.
There is an important point here: some antidepressants may increase sweating in some people. In other words, an antidepressant may reduce sweating in one patient by easing anxiety, while in another patient it may increase sweating as a medication side effect.
If sweating begins after starting an antidepressant or clearly becomes worse, this should be reported to the prescribing doctor.
The medication should not be stopped without medical advice. Sudden discontinuation symptoms, worsening mental health, or other problems may occur.
Hot flashes and night sweats may be common during menopause. This type of sweating is evaluated differently from primary hyperhidrosis.
Treatment options for menopause-related sweating may include:
The most suitable treatment depends on age, severity of menopausal symptoms, history of breast cancer, vascular disease risk, uterine status, current medications, and general health.
In a person with menopausal sweating, gynaecology or endocrinology assessment may be needed before directly considering hyperhidrosis medications.
Some medications may increase sweating.
Medication groups that may cause sweating include certain:
If sweating begins after starting a new medication or becomes more noticeable after a dose increase, the prescribing doctor should be consulted.
Options in this situation may include:
Even if medication side effect is suspected, the medication should not be stopped by the patient. Antidepressants, blood pressure medications, hormone treatments, and nervous system medications in particular should not be discontinued without medical supervision.
Because oral medications have systemic rather than purely local effects, they may reduce sweating in different parts of the body.
They may help with:
However, whole-body action is both an advantage and a disadvantage.
The advantage is that sweating in more than one area may decrease at the same time. The disadvantage is that side effects may occur in different systems such as the mouth, eyes, intestines, bladder, heart rate, and body temperature regulation.
For sweating limited to a single area, local treatments may be more appropriate. In widespread or multi-area sweating, oral medications may become more relevant.
Facial and scalp sweating may be more difficult to treat than sweating in some other areas. This is because antiperspirants, iontophoresis, or botulinum toxin are not always practical in this region.
For this reason, oral medications may be considered in some patients with facial and scalp sweating.
However, the cause of facial sweating should be investigated carefully.
Facial and scalp sweating may be related to:
Treatment changes according to the cause. Starting an anticholinergic medication directly for every patient with facial sweating is not appropriate.
For hand and foot sweating, first options are generally more local methods such as topical products and iontophoresis.
However, oral medications may be considered when:
In people with hand sweating, anticholinergic medications may reduce sweating. However, not everyone can continue them because of side effects such as dry mouth and difficulty tolerating hot weather.
In foot sweating, reduced sweat production may also help decrease slipping inside shoes, wet socks, and moisture-related problems. However, bad odour or fungal infection should be treated separately if present.
Oral medications may be used for underarm sweating, but they are not always the first option.
In primary underarm hyperhidrosis, the following are usually considered first:
Oral medications may be considered especially when:
When sweating is limited only to the underarms, oral medications may not always be the most logical first option because of systemic side effect risk.
The onset of effect varies according to the medication, dose, individual metabolism, and sweating type.
With some medications, the effect may be noticed quickly. With others, dose adjustment and regular use are needed before assessment.
Although reduced sweating may be noticed in the first days, the real effect of treatment and whether side effects are tolerable are usually understood after monitoring for a period.
The doctor may begin with a low dose and adjust according to response and side effects. This approach may help monitor anticholinergic side effects more safely.
The dose should not be increased by the patient simply because the medication seems ineffective early on. Increasing the dose may also increase side effects.
The duration of oral medication treatment varies from person to person.
Some people may use medication only during certain periods or before triggering situations. Others may need regular use.
Treatment duration is determined according to:
With long-term use, side effects, medication interactions, and heat-related risks should be reassessed.
Treatment should be reviewed at regular intervals under medical supervision.
Some medications may be planned for regular daily use. Others may be considered for short-term or intermittent use before specific situations.
For example:
This decision depends on the medication group. Anticholinergic medications, beta blockers, and anti-anxiety medications are not used with the same logic.
A person should not randomly take medication without medical advice just because “I will sweat more today.”
Side effects vary according to the medication group used.
Possible side effects of anticholinergic medications include:
Beta blockers may cause:
Anti-anxiety medications may cause:
For this reason, in oral medication treatment, the question “Has sweating decreased?” is just as important as “Is the medication tolerated?”
Dry mouth is one of the most common side effects of anticholinergic medications.
These medications reduce sweating but may also reduce saliva production. As a result, dryness in the mouth, thirst, difficulty speaking, throat discomfort, and bad breath may occur.
Long-term dry mouth may contribute to:
If dry mouth is significant, the doctor may reassess the dose, medication type, or treatment plan. Dental health and oral hygiene should be considered carefully.
Anticholinergic medications may affect the pupil and tear production.
For this reason, some people may experience:
Anticholinergic medications should be evaluated carefully in people with narrow-angle glaucoma or glaucoma risk. Anyone with a history of eye disease should inform their doctor.
If blurred vision or eye pain develops, the treatment should not simply be continued by the patient; medical assessment should be obtained.
Anticholinergic medications may slow bowel movements and make bladder emptying more difficult.
This may cause:
These effects may become more important in men with prostate enlargement, people with bladder emptying problems, and older patients.
Inability to urinate or significant abdominal swelling may require urgent evaluation.
Yes, it may be risky for some people.
Sweating helps regulate body temperature. Anticholinergic medications may reduce the body’s ability to sweat. This may contribute to increased body temperature, especially in hot weather, humid environments, or during heavy physical activity.
Risk should be assessed more carefully in:
Medical help may be needed if dizziness, weakness, confusion, palpitations, muscle cramps, or a feverish feeling develops in extreme heat.
Thinking “I am not sweating, so there is no problem” while using medication may be misleading. Sometimes the problem is precisely not being able to sweat.
Some oral medications may affect attention, reflexes, and mental performance.
Anticholinergic medications may cause mental clouding, drowsiness, or difficulty focusing in some people. Anti-anxiety medications may cause sedation and slowed reflexes.
These effects may affect:
The person’s occupation and daily activities should be evaluated when starting medication.
Anticholinergic medications are not considered addictive medications. However, they require medical follow-up because of side effects.
Some anti-anxiety medications may carry a risk of dependence, tolerance, and withdrawal symptoms. These medications should not be used long-term or without control.
Medications such as beta blockers and clonidine should also not be stopped suddenly without medical advice. Sudden discontinuation may cause problems related to blood pressure, heart rate, or other symptoms in some people.
For this reason, oral medication treatment should include not only a plan for starting the medication, but also a medically supervised plan for stopping it when needed.
Oral medication treatment may not be suitable for some people.
Anticholinergic medications should be evaluated carefully in the following situations:
Beta blockers may not be suitable in:
Anti-anxiety medications require careful evaluation in alcohol use, history of dependence, jobs requiring attention, and certain breathing problems.
Oral medications used for excessive sweating may interact with other medications.
The doctor should especially be informed about:
Some medications may increase the anticholinergic burden. In this case, dry mouth, constipation, blurred vision, difficulty urinating, and mental clouding may become more noticeable.
All medications and supplements being used should be clearly reported to the doctor. The sentence “It is herbal, so it is harmless” is not enough for medical decision-making. Plants also produce chemicals; their packaging just happens to be leafy.
Oral medication use for excessive sweating during pregnancy and breastfeeding should be evaluated carefully.
Hyperhidrosis is usually not a condition requiring urgent treatment. Therefore, non-medication and safer approaches may be preferred during pregnancy when possible.
During breastfeeding, whether the medication passes into breast milk, possible effects on the baby, and the severity of the mother’s symptoms should be evaluated.
Anyone who may be pregnant or breastfeeding should inform their doctor. Medication should not be started independently.
Excessive sweating in children and adolescents may affect school life, writing, social relationships, and self-confidence.
However, the decision to use oral medication should be made more carefully than in adults.
Assessment should consider:
Oral hyperhidrosis medication in children should only be considered under the supervision of doctors experienced in this field.
Oral medication treatment should be evaluated more carefully in older adults.
Anticholinergic medications may be more problematic in older age because of:
Multiple medication use is also more common in older adults. This may increase anticholinergic burden and side effect risk.
If sweating begins for the first time in older age, secondary causes should be investigated before assuming primary hyperhidrosis.
In many patients, oral medications may be considered before surgical treatment. However, this is not a mandatory step for every patient.
For example, in severe hand sweating, the following may be ordered according to the patient’s situation:
Surgical treatment is generally considered in suitable patients whose quality of life is seriously affected, who have not benefited sufficiently from less invasive methods, and who understand the surgical risks.
If side effects of oral medications are not tolerated or the benefit is insufficient, other non-surgical methods or surgical options may be reassessed.
Combination treatment may be considered in some patients.
For example:
may be planned together.
However, this decision should be made individually for each patient. Combining more than one treatment may increase the effect, but it may also increase side effects and the need for monitoring.
Suppressing sweating in very large areas at the same time may require caution for body temperature regulation in hot weather.
Combination treatment should be planned under medical supervision.
Yes. In some patients, oral medications and iontophoresis may be considered together.
Especially in hand and foot sweating, iontophoresis may provide local control while oral medication may help reduce sweating in other areas.
However, the treatment plan should consider:
Starting oral medication may not make iontophoresis maintenance sessions completely unnecessary. Treatment is adjusted individually.
There is no single answer to this question.
Oral medications may affect sweating in more than one area. Therefore, they may be advantageous in widespread or multi-area hyperhidrosis.
However, local treatments may be more targeted in specific areas:
The disadvantage of oral medications is the risk of systemic side effects. Therefore, the goal should not be to find the “most effective” treatment in general, but the most suitable and sustainable treatment for the individual patient.
If oral medication does not provide sufficient benefit or cannot be continued because of side effects, the treatment plan should be reassessed.
The following questions should be reviewed first:
Then the following options may be considered:
Failure of medication alone does not mean “surgery is now mandatory.” Treatment steps are replanned according to the patient.
When using oral medication for sweating, the doctor’s recommendations should be followed.
Important points include:
The ability to continue the medication safely is as important as whether it works.
Some symptoms during oral medication use require medical evaluation.
A doctor should be contacted in the following situations:
Chest pain, shortness of breath, confusion, fainting, serious allergic reaction, or inability to urinate may require urgent evaluation.
Initial assessment may be performed by a family physician, internal medicine specialist, or dermatologist.
Depending on the location and cause of hyperhidrosis, different specialists may be involved:
Oral medication treatment requires medical supervision, especially because of existing diseases and other medications being used.
Oral medication treatment is available for excessive sweating. The most commonly considered medication group is anticholinergic medications. These medications may reduce sweat production by decreasing the effect of acetylcholine reaching the sweat glands.
Oral medications may be considered especially in patients who sweat in more than one area, do not benefit sufficiently from local treatments, or have sweating in areas that are more difficult to treat, such as the face and scalp.
However, these treatments may affect not only the sweat glands but also other body systems. Side effects such as dry mouth, constipation, blurred vision, difficulty urinating, palpitations, drowsiness, and heat intolerance may occur.
Beta blockers may be considered in some performance-related or anxiety-associated sweating situations. Clonidine may be considered in certain hot-flash or face-and-scalp sweating patterns. Anti-anxiety medications may be considered in limited situations after psychiatric evaluation.
If sweating begins suddenly, continues at night, affects the entire body, or occurs with symptoms such as fever, weight loss, palpitations, and trembling, secondary causes should be investigated before oral medication is started.
The most appropriate treatment should be planned individually according to the type and severity of sweating, affected areas, age, occupation, accompanying diseases, current medications, and tolerance of side effects.
Yes. Oral medications are available for excessive sweating. The most commonly considered group is anticholinergic medications. However, these medications are not suitable for everyone and should be used under medical supervision.
Anticholinergic medications may reduce sweat production by decreasing the effect of acetylcholine reaching the sweat glands. Some medications may act indirectly by reducing anxiety, palpitations, hot flashes, or other underlying mechanisms.
They may reduce hand and foot sweating in some patients. However, local methods such as antiperspirants, iontophoresis, and botulinum toxin are also evaluated for hand and foot sweating. The suitable option depends on the patient.
Oral medications may be considered in some patients with facial and scalp sweating. However, it should first be assessed whether the sweating is related to primary hyperhidrosis, menopause, thyroid disease, medication side effects, social anxiety, or another cause.
Side effects vary according to the medication. Anticholinergic medications may cause dry mouth, constipation, blurred vision, difficulty urinating, palpitations, drowsiness, and heat intolerance.
No. Oral medications generally work while they are being used. Sweating may return when the medication is stopped. They are not considered a permanent treatment.
This depends on the patient. Botox may provide a strong local effect in a specific area. Oral medications may affect sweating in several areas but carry a risk of systemic side effects.
Some medications may reduce sweating and affect the body’s ability to regulate heat. People who work in hot environments, athletes, older adults, and those with heart disease should be evaluated more carefully.
The decision to use oral medication in children and adolescents should be made very carefully. Age, weight, severity of sweating, school life, side effect risk, and alternative treatments should be assessed. They should not be used without medical supervision.
Initial assessment may be performed by dermatology, internal medicine, or family medicine. Endocrinology may be needed for hormonal causes, gynaecology for menopause, psychiatry for social anxiety, and thoracic surgery for surgical options.